IP Library Granted Patent US 8,251,985
Granted Patent B2
US 8,251,985 · App. 12/614,218 · Granted Aug 28, 2012

Systems and methods for treatment of prostatic tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,251,985
App. No.
12/614,218
Granted
Aug 28, 2012
Kind
B2
Abstract

A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.

Claims (15)

1. A method of treating a disorder of a prostate adjacent a prostatic urethra, the method comprising:

advancing a vapor ablation probe transurethrally into the prostate;

delivering condensable vapor into the prostate, the condensable vapor undergoing a phase change to deliver between 100 and 10,000 Joules to the prostate; and

ablating prostate tissue without ablating the prostatic urethra.

2. The method of claim 1 wherein the advancing step comprises advancing the vapor ablation probe into an apex of a lobe of the prostate.

3. The method of claim 1 wherein the condensable vapor delivers between 100 W and 400 W to the prostate.

4. The method of claim 1 wherein the condensable vapor delivers between 250 cal/gm and 450 cal/gm to the prostate.

5. The method of claim 1 wherein the condensable vapor delivers between 20 W and 100 W to the prostate.

6. The method of claim 1 wherein the condensable vapor delivers between 100 cal/gm and 600 cal/gm to the prostate.

7. The method of claim 1 wherein the introducing step comprises advancing the ablation probe at least 15 mm into the prostate.

8. The method of claim 1 wherein the introducing step comprises introducing condensable vapor into the prostate through a plurality of vapor ports in the ablation probe.

9. The method of claim 8 wherein the introducing step comprises orienting the vapor ports toward the urethra.

10. The method of claim 1 wherein the introducing step comprises advancing an introducer into a urethra and advancing the ablation probe through the introducer.

11. The method of claim 10 further comprising placing a port of the introducer against a urethral wall prior to advancing the ablation probe through the introducer.

12. The method of claim 10 wherein at least part of the introducer probe and at least part of the ablation probe have complementary shapes preventing rotation of the ablation probe within the introducer.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded May 21, 2019
From: NXTHERA, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 049240/0378 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2018
From: EAST WEST BANK
To: NXTHERA, INC.
Reel/Frame 045825/0641 →
SECURITY INTEREST Recorded Dec 10, 2015
From: NXTHERA, INC.
To: EAST WEST BANK
Reel/Frame 037265/0505 →
SECURITY INTEREST Recorded Dec 1, 2015
From: NXTHERA, INC.
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 037183/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: HOEY, MICHAEL; SHADDUCK, JOHN H.
To: NXTHERA, INC.
Reel/Frame 024568/0931 →